Back to mobile site

Vaxcyte (PCVX) PT Set at $120 at Cantor Fitzgerald - Pressure on Shares Explained by Challenging Market

October 12, 2026 7:10 AM EDT Send to a Friend
Cantor Fitzgerald analyst Carter Gould set the price target on Vaxcyte (NASDAQ: PCVX) to $120.00 from NA while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login